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ARTICLE
Diverse motif ensembles specify non-redundant
DNA binding activities of AP-1 family members in
macrophages
Gregory J. Fonseca1, Jenhan Tao1, Emma M. Westin1, Sascha H. Duttke2, Nathanael J. Spann1, Tobias Strid1,
Zeyang Shen3, Joshua D. Stender1, Mashito Sakai1, Verena M. Link4, Christopher Benner2 &
Christopher K. Glass1,2
Mechanisms by which members of the AP-1 family of transcription factors play non-
redundant biological roles despite recognizing the same DNA sequence remain poorly
understood. To address this question, here we investigate the molecular functions and
genome-wide DNA binding patterns of AP-1 family members in primary and immortalized
mouse macrophages. ChIP-sequencing shows overlapping and distinct binding profiles for
each factor that were remodeled following TLR4 ligation. Development of a machine learning
approach that jointly weighs hundreds of DNA recognition elements yields dozens of motifs
predicted to drive factor-specific binding profiles. Machine learning-based predictions are
confirmed by analysis of the effects of mutations in genetically diverse mice and by loss of
function experiments. These findings provide evidence that non-redundant genomic locations
of different AP-1 family members in macrophages largely result from collaborative interac-
tions with diverse, locus-specific ensembles of transcription factors and suggest a general
mechanism for encoding functional specificities of their common recognition motif.
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Gene expression is controlled by sequence-specific tran-scription factors (TFs) which bind to promoters and distalenhancer elements1–3. Genome wide studies of regulatory
regions in diverse cell types suggest the existence of hundreds to
thousands of enhancer sites within mammalian genomes. Each
cell type selects a unique combination of ~20,000 such sites that
play essential roles in determining that cell's identity and func-
tional potential4–7. Selection and activation of cell-specific
enhancers and promoters are achieved through combinatorial
actions of the available sequence-specific TFs8–14.
TFs are organized into families according to conserved protein
domains including their DNA binding domains (DBD)15. Each
family may contain dozens of members which bind to similar or
identical DNA sequences16,17. An example is provided by the AP-1
family, which is composed of 15 monomers subdivided into five
subfamilies based on amino acid sequence similarity: Jun (Jun,
JunB, JunD), Fos (Fos, FosL1, FosL2, FosB), BATF (BATF, BATF2,
BATF3), ATF (ATF2, ATF3, ATF4, ATF7), and Jdp218–22. AP-1
binds DNA as an obligate dimer through a conserved bZIP
domain. All possible dimer combinations can form with the
exception of dimers within the Fos subfamily23. The DBD of each
monomer of the AP-1 dimer recognizes half of a palindromic
DNA motif separated by one or two bases (TCASTGA and
TCASSTGA)16,17,24–26. Previous work has shown that dimers
formed from Jun and Fos subfamily members bind the same
motif16. Given a conserved DBD, and the ability to form hetero-
dimers, it naturally follows that different AP-1 dimers share reg-
ulatory activities. However, co-expressed family members can play
distinct roles20,27–30. For example, Jun and Fos are co-expressed
during hematopoiesis, but knockout of Jun results in an increase in
hematopoiesis whereas knockout of Fos has the opposite
effect20,28–30. The basis for non-redundant activities of different
AP-1 dimers and heterodimers remains poorly understood.
Specific AP-1 factors have been shown to form ternary com-
plexes with other TFs such as IRF, NFAT, and Ets proteins,
resulting in binding to composite recognition elements with fixed
spacing31–33. However, recent studies examining the effects of
natural genetic variation suggested that perturbations in the DNA
binding of Jun in bone marrow-derived macrophages are asso-
ciated with mutations in the motifs of dozens of TFs that
occurred with variable spacing34. These observations raise the
general question of whether local ensembles of TFs could be
determinants of differential binding and function of specific AP-1
family members. To explore this possibility, we examined the
genome-wide functions and DNA binding patterns of co-
expressed AP-1 family members in resting and activated mouse
macrophages. In parallel, we developed a machine learning
model, called a transcription factor binding analysis (TBA), that
integrates the affinities of hundreds of TF motifs and learns to
recognize motifs associated with the binding of each AP-1
monomer genome-wide. By interrogating our model, we identi-
fied DNA binding motifs of candidate collaborating TFs that
influence specific binding patterns for each AP-1 monomer that
could not be identified with conventional motif analysis. We
confirmed these predictions functionally by leveraging the natural
genetic variation between C57BL/6J and BALB/cJ mice, and
observing the effects of single nucleotide polymorphisms (SNPs)
and short insertions or deletions (InDels) on AP-1 binding.
Finally, we confirm the models prediction of PPARγ binding
being specifically associated with the selection of a single family
member, Jun, using PPARγ-deficient macrophages.
Results
AP-1 members have distinct functions in macrophages. AP-1
family members are ubiquitously expressed with each cell type
selecting a subset of family members (monomers), which make
up the AP-1 dimer. Each family member shares a conserved DNA
binding and dimerization domain but are dissimilar outside of the
basic leucine zipper (bZIP domain, Fig. 1a). For this study, we will
focus on thioglycollate elicited macrophages (TGEMs). TGEMs,
which are a classical primary macrophage population, are pro-
duced by injection of thioglycolate into the peritoneal space.
Macrophages are then recruited to the peritoneum and can be
easily isolated by flushing the peritoneal cavity 3 days after
treatment. RNA-seq performed on TGEMs revealed ATF3, Jun,
and JunD as the most expressed AP-1 family members under
basal conditions (Veh), (Fig. 1a, Supplementary Fig. 1A). Fol-
lowing activation of TGEMs with Kdo2 lipid A (KLA), a specific
agonist of TLR435, there is a marked increase in Fos, Jun, and
JunB expression, consistent with AP-1 family members having
context-specific roles (Fig. 1a).
To examine the regulatory function of individual family
members, knockout cell lines for ATF3, Jun, and JunD were
produced using CRISPR/Cas9-mediated mutagenesis in immor-
talized bone marrow-derived macrophages (iBMDMs). Knockout
efficiency was confirmed by western blotting (Supplementary
Fig. 1B). RNA-seq analysis identified 2496 genes differentially
expressed when comparing the knockout to control cells (false
discovery rate (FDR) < 0.05, fold change > 2, Reads Per Kilobase
of transcript per Million mapped reads (RPKM) ≥ 16; Fig. 1b,
Supplementary Fig. 1C). Clustering of differentially expressed
genes revealed distinct clusters that were affected in individual
knockout cell lines, demonstrating that each family member can
have distinct as well as redundant activity within a single cell type
and corroborating previous studies20,27–30. The Jun knockout had
a more modest effect on gene expression than the ATF3 and JunD
knockout (125, 651, and 1564 differentially expressed genes
respectively), suggesting that Jun may have more redundant
activity (Fig. 1b and Supplementary Fig. 1C). Each of the gene
clusters was enriched for Gene Ontology terms for differing
biological functions, including cell cycle, immune effector
process, and NADPH complex assembly (Fig. 1b). Examples of
affected genes are shown in Fig. 1c. Mmp12 is affected by
knockdown of all three factors, whereas Marco and Fth1 exhibit
minimal changes in expression in ATF3 and Jun KO, but
decreased expression in the JunD KO iBMDMs.
AP-1 members target distinct in addition to overlapping loci.
Given the distinct roles of individual family members in reg-
ulating macrophage transcription, we used chromatin immuno-
precipitation followed by deep sequencing (ChIP-seq) to map the
binding of each family member in resting TGEMs treated with
vehicle (Veh) or KLA for 1 h (activated TGEMs). Not surpris-
ingly, these experiments detected a substantial number of binding
sites (n > 10,000, irreproducible discovery rate (IDR) < 0.05) for
family members with the highest mRNA expression (Supple-
mentary Fig. 1A, Supplementary Fig. 2A). ATF3, Jun, and JunD
binding sites were detected in both Veh and KLA treatment
whereas Fos, Fosl2, and JunB bind predominantly after KLA
treatment (Supplementary Fig. 2A). Despite high RNA expression
in Veh treatment, JunB protein expression was not detected in the
nucleus by western blot, explaining a lack of ChIP-seq signal
(Supplementary Fig. 2B). Though ATF4 is highly expressed by
RNA, we were unable to detect ATF4 by ChIP-seq using several
conditions and several different antibodies. Hierarchical cluster-
ing of all 50,664 AP-1 binding sites (Fig. 2a) found in either Veh
or KLA treated TGEMs according to the relative binding strength
of the family members (normalized to a maximum of 1 at each
locus) yielded distinct subclusters that highlight the specific
binding patterns of AP-1 family members as well as the
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Fig. 1 AP-1 proteins have overlapping and distinct transcriptional functions in macrophages. a Protein alignment of monomers (right) and mRNA expression
of monomers in thioglycollate elicited macrophages before and after 1-h Kdo2 lipid A treatment (left). b Hierarchical clustering of genes that are
differentially expressed in immortalized bone marrow-derived macrophages subjected to CRISPR-mediated knockdown of the indicated AP-1 monomer
with respect to scramble control. Expression values are given as the fold change with respect to scramble; values are Z-score normalized across each row.
Representative functional annotations for each gene cluster are calculated using Metascape and the enrichment of each term is quantified as the negative
log transform of the p-value. c Expression of a subset of genes in AP-1 protein knockouts. n=2. End points of the error bars indicate the value from each
replicate. * indicates False discovery rate (FDR) < 0.05
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Fig. 2 AP-1 monomers bind at unique loci that cannot be explained by differences in the DNA binding domain. a Hierarchical clustering of the relative
strength of binding of each monomer at all AP-1 binding sites in Vehicle and 1-h Kdo2 lipid A (KLA) treatment conditions. b Representative browser shots
of ChIP-seq peaks for Veh-specific monomers ATF3, Jun, and JunD. c Genome run-on sequencing at sites where ATF3, Jun, and JunD were lost, gained, or
unchanged after 1 h KLA treatment. d Venn diagram of ATF3, Jun, and JunD peaks in Vehicle (left) and table indicating the de novo AP-1 motifs found in
each subset of peaks and the percent of peaks in each subset that contain one of the two AP-1 motif variants (right). e Binding strength comparison of
ATF3 chimeras. The ATF3 DNA binding domain (blue) is replaced by the DNA binding domains of Fos (yellow) or Jun (green) and then transduced into
ATF3-deficient immortalized bone marrow-derived macrophage cells with a lentivirus vector (left). The binding of each chimera is shown as a heatmap of
ChIP-seq tags centered on ATF3 chimera binding sites (replicates indicated in separate rows) that were found to be specific for ATF3 (blue) or Jun binding
in thioglycollate elicited macrophages (green). f Heatmap showing the percent of unique binding sites for each monomer that contain a de novo motif
calculated from each set of unique peaks. * indicates p < 0.01, for all comparisons between Lost in KLA, Unchanged Veh to KLA, and Gained in KLA for each
AP-1 family member, independent T-test
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reorganization of AP-1 cistromes in KLA treated macrophages
(Fig. 2a). Representative regions that show distinct binding pat-
terns of AP-1 family members are shown (Fig. 2b, Supplementary
Fig. 2C).
The gain and loss of binding sites of ATF3, Jun, and JunD after
KLA treatment provided an opportunity to correlate changes in
their DNA occupancy with local changes in enhancer activity.
Changes in the expression of enhancer-associated RNAs (eRNAs)
are highly correlated with changes in enhancer function and
nearby gene expression11. To detect eRNAs, we performed
genome run-on sequencing (GRO-seq) in TGEMs, which
provides a quantitative measure of nascent RNA36. We examined
GRO-seq signal at ATF3, Jun, and JunD binding sites exhibiting
gain, loss, or no change in binding after KLA treatment. In each
case, AP-1 occupancy was associated with greater GRO-seq signal
(Fig. 2c). These findings suggest that ATF3, Jun, and JunD
primarily function as transcriptional activators.
Member specific loci are associated with a shared DNA motif.
While 10,514 binding sites of ATF3, Jun, and JunD in the vehicle
condition are shared by all three factors, a greater number of
binding sites (11,530) are not (Fig. 2d). To ensure that the unique
sites were not technical artifacts, we ranked the peaks of each
family member according to the number of ChIP-seq tags
detected and then calculated the percent of peaks that were
unique after filtering away binding sites that fell below a given
percentile threshold. We found that unique peaks were present
even at higher thresholds, supporting our observation that AP-1
family members can bind to distinct loci (Supplementary
Fig. 2D).
Using de novo motif enrichment analysis, we observed that the
binding motif for each combination of monomers was nearly
identical (Fig. 2d). To investigate whether family members
preferred either variant of the AP-1 motif, we calculated the
percent of peaks bound by each combination of monomers that
had the TRE variant of the AP-1 motif (TGASTCA) and the CRE
variant of the motif (TGASSTCA)16,37. Consistent with previous
studies, we found both variants of the AP-1 motif at regions
bound by each combination of monomers, but there was a
preference for the TRE motif (Fig. 2d)16. These results suggest
that differences in the AP-1 DBD cannot explain the majority of
family member specific binding.
To test the prediction that differences in the AP-1 DBD do not
explain binding patterns, we created ATF3 chimeras by replacing
the DBD of ATF3 with that of Fos and Jun (Fig. 2e,
Supplementary Fig. 2E). The DBDs of these three factors are
highly conserved, with identity at 8 and charge conservation at 3
of 11 amino acids directly involved in DNA interaction
(Supplementary Fig. 2E)24. We transduced expression vectors
for ATF3 chimeras with either an ATF3, Fos, or Jun DBD into
ATF3 KO iBMDMs and then measured the genome-wide binding
patterns of each chimera by performing ChIP-seq using an
antibody specific for ATF3 (Fig. 2e). Globally, we observed that
the chimeras had stronger binding at ATF3 specific sites in
comparison to Jun-specific sites and that each chimera exhibited
similar binding across all loci visualized as normalized tag counts
in a heatmap (Fig. 2e). Representative browser shots showing
similar binding between chimeras are shown at Cxcl10 and Spsb1
which are loci specifically bound by ATF3 and Jun, respectively
(Supplementary Fig. 2F).
Given that the family members all recognized a common DNA
binding motif, we hypothesized that differential interactions with
locally bound factors mediated by non-conserved protein contact
surfaces may explain unique monomer binding sites. We
calculated de novo motifs enriched at the unique peaks for
ATF3, Jun, and JunD individually, and then calculated the
percent of each family members specific binding sites that
contained a match to each de novo motif. We identified motifs for
key TFs in macrophages10,34 such as PU.1, CEBP, and Runx
(Fig. 2f). Composite motifs for AP-1 and IRF or NFAT occurred
at similar frequencies at the unique peaks for each family member
(~5% and ~3% of peaks, respectively). However, we found no
significant differences in the relative enrichment of motifs
associated with ATF3, Jun, and JunD specific peaks that would
explain their specific binding profiles (Fig. 2f).
Machine learning links combinations of motifs to TF binding.
Given the robustness of the family member specific peaks (Sup-
plementary Fig. 2D), we considered additional biological
mechanisms that might be leveraged for detection of motifs dif-
ferentially associated with each family member. Current methods
for calculating enriched motifs analyze each motif individually
despite data demonstrating that TFs bind cooperatively in
groups1,31. Additionally, collaborative binding by TFs allows for
partners to bind to more degenerate motifs, which are ignored in
de novo motif analysis10. We incorporated these concepts into a
machine learning model that relates the presence of multiple TF
motifs, which may be degenerate, to the binding of a TF. Machine
learning models are often considered difficult to interpret due to
their complexity. In building our model, we emphasized simpli-
city and as a consequence, interpretability.
Figure 3a summarizes our model, TBA. TBA uses logistic
regression to learn to distinguish the binding sites of a TF from a
set of GC-matched background loci. For each binding site and
background locus, TBA calculates the best match to hundreds of
DNA binding motifs, drawn from the JASPAR library, and
quantifies the quality of the match as the motif score (aka log-
likelihood ratio score). To allow for degenerate motifs, all motif
matches scoring over zero are considered. The motif scores are
then used to train the TBA model to distinguish TF binding sites
from background loci. TBA scores the probability of observing
binding at a sequence by computing a weighted sum over all the
motif scores for that sequence. By considering all motifs
simultaneously, TBA can learn to recognize combinations of
motifs that are co-enriched at TF binding sites but that are not
individually enriched over genomic background. The weight for
each motif is learned by iteratively modifying the weights until
the models ability to differentiate binding sites from background
loci no longer improves. The final motif weight measures whether
the presence of a motif is correlated with TF binding. The
significance of a given motif can be assigned by comparing the
predictive performance of a trained TBA model and a perturbed
model that cannot recognize that one motif with the likelihood
ratio test.
Machine learning models, including TBA, can be confounded
by collinearity, which in our case corresponds to the presence of
motifs that are highly similar or redundant38. Collinearity can
cause inaccurate weight and significance to be assigned to motifs.
To assess the extent of collinearity, we calculated the variance
inflation factor (VIF)38 for the scores of each motif in the
JASPAR library at AP-1 binding sites. A VIF above 10 would
indicate problematic collinearity and that the scores for a motif
are highly correlated with the scores of another motif. We found
that a substantial number of motifs were collinear with at least
one other motif (VIF > 10) (Fig. 3b, c). To address the presence of
redundant motifs we clustered the JASPAR library, identifying
groups of motifs that are highly similar (Supplementary Fig. 3,
colored clades), and merged these motifs together (Pearson
correlation > 0.9, Supplementary Fig. 3, Fig. 3a), resulting in a
condensed library of 196 motifs formed from 519 JASPAR motifs.
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Multiple collinearity was substantially reduced in our condensed
library (VIF < 10, Fig. 3b, c).
TBA identifies combinations of motifs that coordinate AP-1.
To identify motifs associated with specific AP-1 family members,
we trained TBA models for each monomer in resting TGEMs,
and probed for differences in the identified motifs. Ranking each
motif according to the mean p-value, we found that all family
members shared a core set of highly significant motifs both
positively and negatively correlated with binding (Fig. 4a, i and ii,
respectively). The motifs exhibiting strong positive correlation
included the AP-1 motif as well as motifs of macrophage colla-
borative binding partners for AP-1, such as PU.1 and
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CEBP10,11,34. To determine a significance threshold for more
moderately ranked motifs, we compared significance values cal-
culated by TBA models trained on replicate ChIP-seq experi-
ments. We determined that motifs with a mean p-value < 1e−2.5
tended to have similar significance values (absolute likelihood
ratio ~1, Supplementary Fig. 4A). The motif weights that excee-
ded this threshold were highly correlated between replicate
experiments (Supplementary Fig. 4B). Outside of the core group
of motifs shared by all monomers, we observed ~50 motifs with
differential affinities (likelihood ratio > 100 between at least 2
monomers) for each monomer as defined by TBA (Fig. 4a, center
panel, shaded regions). Differential motifs positively correlated
with binding (Fig. 4a, left heatmap in red) included motifs unique
to a monomer such as the PPAR half site with Jun. The full
PPARγ motif was negatively correlated with both ATF3 and
JunD, suggesting that PPARγ positively influences the binding of
Jun to a greater extent than the other AP-1 monomers (Fig. 4a,
right heatmap in blue). These results suggest that AP-1 mono-
mers have distinct sets of collaborating TFs that affect their
binding patterns.
Evaluation of TF motifs that coordinate AP-1 binding. To
assess whether the additional motifs identified by TBA are useful
for identifying AP-1 sites, we compared TBAs ability to predict
the binding of each monomer to several other sequence-based
approaches. Predicting TF binding using just the AP-1 TRE motif
score had the worst performance as measured by the area under
the receiver operating characteristic curve (auROC; Fig. 4b).
Bayesian Markov Model motifs (BaMM)39, which assesses
dependencies between the positions within the binding motif,
improved upon the simple AP-1 motif score by ~15% (Fig. 4b).
The TBA model and the gkm-SVM model achieved even higher
performance, demonstrating that additional sequences outside of
a TFs motif may contribute to binding site selection (Fig. 4b). The
performance of gkm-SVM exceeded that of TBA (by ~3%).
However, a greater number of motifs related to the binding of a
TF can be extracted from TBA in comparison to gkmSVM. The
authors of gkm-SVM described a procedure to retrieve up to
three PWMs from k-mers ranked by gkmSVM40, while TBA
identified over 50 motifs that passed a significance threshold of
p < 1e−2.5 (Fig. 4c). To examine the impact of statistically sig-
nificant (p < 1e−2.5) but moderately ranked motifs, we calculated
TBAs performance while iteratively removing motifs from the
model (starting with the least significant motif) (Fig. 4d). The
performance of the model started declining when the motifs from
the top 50 were removed, demonstrating that the local sequence
environment outside of the AP-1 motif affects AP-1 binding
(Fig. 4d, inset).
Cell type-specific binding preferences of JunD. To further test
the hypothesis that distinct sets of collaborating TFs can affect
AP-1 binding, we examined JunD binding in a panel of cell lines.
Each cell type expresses a distinct repertoire of TFs that are
available as binding partners for JunD. We trained TBA models
for ChIP-seq of JunD in each cell line and then extracted the 20
most significant motifs from each model. Motifs which are bound
by TFs known to be important for particular cell lines were found
to be correlated with JunD binding. For example, the Gata motif
was positively correlated with JunD binding in K562 cells, an
erythroid lineage erythroleukemia, while Pou motifs (e.g., OCT4)
were important in h1-hESCs (Supplementary Fig. 4C)41. Differ-
ences in the motifs identified by TBA for each cell line corre-
sponded to large differences in the loci bound by JunD
(Supplementary Fig. 4D), suggesting that JunD interacts with
different TFs depending on the expressed binding partners
available in each cell type42.
KLA changes the available TFs that remodel the AP-1 cistrome.
Given that AP-1 binds collaboratively with other TFs, the selec-
tion of binding sites for each monomer will depend on the
availability of collaborating partners. To study effects of changes
in collaborating TF availability, we examined AP-1 binding before
and after KLA treatment. Treatment of TGEMs with KLA
resulted in 178 mRNAs increasing 2-fold (FDR < 0.05) or greater
(Supplementary Fig. 5A). A total of 29 genes encoding TFs with
known binding motifs (20 upregulated and 9 downregulated) had
a significant change in expression (FDR < 0.05) including AP-1
monomers Fos, Fra2, and JunB (Supplementary Fig. 5A). In
addition, TLR4 activation by KLA results in the activation of
several latent TFs, including NFκB and interferon regulatory
factors (IRFs). Correspondingly, AP-1 monomers showed chan-
ges in their global binding patterns with Fos and JunB displaying
drastic upregulation in binding sites (Supplementary Fig. 2A,
Fig. 5a).
To examine motifs associated with AP-1 binding after KLA
treatment, we trained TBA models for each monomer in KLA
treated TGEMs. Again, we observed that all AP-1 monomers
shared a common group of highly significant motifs positively
correlated with binding, including AP-1, CEBP, PU.1, REL, and
Egr, and negatively correlated with binding, such as the Zeb1
motif (Supplementary Fig. 5B, Supplementary Table 1, Supple-
mentary Table 2). Many of the moderately ranked motifs showed
large differences in significance between the monomers (Supple-
mentary Fig. 5B, Fig. 5c: likelihood ratio > 100).
We found that AP-1 monomers with substantive binding
before KLA treatment (ATF3, Jun, and JunD) showed changes in
their preference (as measured by the likelihood ratio for each
motif when comparing the KLA and Vehicle TBA models) for
motifs bound by upregulated TFs such as Rel, Irf3/7/8/9, Irf2, and
Nfat (Fig. 5b, likelihood ratio > 10e4). Conversely, down-
regulated TFs were found to have reduced significance for all
AP-1 monomers after 1-h KLA treatment including Usf (Fig. 5b,
likelihood ratio <1e−4). AP-1 monomers activated after 1-h KLA
treatment (Fos, FosL2, and JunB) (Figs. 2a and 5a) also showed an
affinity for the Rel, Nfat, Irf3/7/8/9, and NFκB motifs (Fig. 5b).
To assess the extent to which individual TF motifs could
explain the change in binding after KLA treatment, we calculated
the correlation of each motifs score to the change in binding after
KLA treatment at all loci (Fig. 5c). We found that motifs with
large changes in significance when comparing the Vehicle and
KLA TBA models for each monomer showed higher correlations
to the change in binding after KLA treatment and that these
motifs corresponded to well-established TLR4 activated TFs such
as Rel, NFAT, and NFκB (Fig. 5b, c)11,31. To demonstrate that
combinations of TFs can better explain the change in AP-1
binding after KLA treatment, we used TBA to predict the change
in binding after KLA treatment. We calculated a predicted change
in binding by taking the difference of the predicted binding
strength given by the Vehicle and KLA model for each monomer
(Fig. 5d–f). We found that TBA could predict the change in
binding after KLA treatment better than any individual motif
(Fig. 5c).
Systematic validation of TBA using natural genetic variation.
To validate the results of our machine learning model genome
wide, we used natural genetic variation found between C57BL6/J
and BALBc/J mice, which differ genetically by ~5 million SNPs
and insertions/deletions (InDels)43. We have previously shown
that mutations which occur within DNA binding motifs can be
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used to predict genetic interactions between TFs10,34. We per-
formed ChIP-seq targeting expressed AP-1 monomers, ATF3,
Fos, FosL2, Jun, JunB, and JunD in TGEMs isolated from BALB/
cJ mice. Mutations can be found in ~17% of each monomers
binding sites, and one-third of those loci show strain-specific
binding (fold change > 2), as shown for ATF3 (Fig. 6a). These
binding differences cannot be attributed to differences in mRNA
or protein expression levels, which are highly similar (Supple-
mentary Fig. 6A, B). We observed that TBA models trained on
either strain could be used to predict binding in the other with no
loss of predictive ability (Supplementary Fig. 6C), suggesting that
each monomer, which has identical protein sequence in both
strains, interacts with the same repertoire of collaborating TFs in
both strains.
To assess the extent to which SNPs/InDels in individual motifs
explain strain-specific binding, we calculated the difference
between the best matching motif score at every loci between
the strains and then calculated the Pearson correlation to the
change in binding (Fig. 6b, Supplementary Fig. 6D). Mutations in
individual motifs showed a weak correlation to strain-specific
binding (Fig. 6b, Supplementary Fig. 6D). We found that motifs
identified with TBA (p < 1e−2.5) are enriched at strain-specific
peaks in comparison to non-strain-specific peaks, but that
mutations in any individual motif do not occur frequently
enough to explain the majority of strain-specific binding (Fig. 6c,
Supplementary Fig. 6E). We integrated the contributions of
multiple motifs to strain-specific binding, by weighting the motif
score difference with the TBA calculated weight, and were able to
predict strain-specific binding with a 2-fold improvement in
performance in comparison to using the AP-1 motif score
(Fig. 6b, Supplementary Fig. 6D)
Next, we created a variant of our model, which we call TBA-
2Strain, that directly learns from genetic variation (Fig. 6d). TBA-
2Strain takes genetic variation as input (quantified as the change
in motif scores between the two strains) and the extent of strain-
specific binding for each AP-1 monomer. Using TBA-2strain, we
predicted strain-specific binding at all binding sites with a
mutation (Fig. 6b). In comparison to TBA, TBA-2Strain has
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better predictive performance (Fig. 6b). This may be attributed to
TBA-2Strain being able to observe sites that contain mutations
but do not exhibit strain-specific binding. The ability of TBA-
2Strain to predict strain-specific binding improves upon
deltaSVM, a state of the art tool for predicting the effect of
genetic variation40 (Fig. 6b, Supplementary Fig. 6D).
We then extracted significant motifs from TBA-2Strain using
the F-test (p < 0.05) and intersected these motifs with motifs
identified by TBA model (Figs. 4a and 6e). We found that the
motifs from both models overlapped substantially (Fig. 6e, p <
0.05, Fisher’s exact test), reinforcing the notion that dozens of
motifs contribute to coordinating the targeting of AP-1 mono-
mers. Significance values for motifs identified by both models are
shown from resting and activated TGEMs (Fig. 6e, Supplemen-
tary Fig. 6F). Notably, the PPARγ half-site was detected by both
the TBA and TBA-2Strain models.
Validation of PPARγ as a preferential modifier of Jun. TBA
and TBA-2Strain predicted that PPARγ is a preferential colla-
borating TF specific to Jun in resting macrophages (Figs. 4a and
6e). To confirm this prediction, we performed ChIP-seq for
ATF3, Jun, JunD, and PPARγ in wild type and PPARγ knockout
mouse TGEMs (Fig. 7a–c)44. Representative browser tracks are
shown for Jun binding in wild-type and PPARγ knockout mac-
rophages (Fig. 7d). The protein expression of ATF3, Jun, and
JunD are unchanged in PPARγ knockout TGEMs in comparison
to wild type (Fig. 7e). ChIP-seq experiments in PPARγ knockout
TGEMs show a marked reduction in Jun binding (Fig. 7a). In
contrast, ATF3 and JunD show little change in binding (Fig. 7b,
c). We found that PPARγ bound loci where Jun binding is lost in
the PPARγ knockout tended to score higher for the PPARγ half
site motif in comparison to Jun bound loci that did not overlap
with PPARγ binding (independent T-test p < 5e−05). To verify
the specificity of the Jun antibody we also performed ChIP-seq on
Jun in CRISPR mediated Jun knockout iBMDM cells and
iBMDM transduced with scramble control. We observed sub-
stantial loss of Jun binding in the Jun KO cells in comparison to
iBMDM cells transduced with scramble control (12 versus 25,041
peaks detected with IDR < 0.05) (Supplementary Fig. 7). Collec-
tively, these results confirm that PPARγ specifically affects Jun
recruitment.
We then probed the interactions between PPARγ and AP-1
family members by co-immunoprecipitation. ATF3, Jun, and
JunD co-precipitated with PPARγ (Fig. 7e). As AP-1 binds as a
dimer, ATF3 and JunD may be interacting with PPARγ indirectly
by dimerizing with Jun. To confirm that Jun is required for
interaction of ATF3 and JunD with PPARγ, we performed Co-IP
from iBMDM cells in which Jun was knocked out using CRISPR/
Cas9 (Supplementary Fig. 1B). We found a loss of interaction
between PPARγ and ATF3 or JunD in JunKO cells as compared
to scramble control (Fig. 7f). This suggests that ATF3 and JunD
do not interact with PPARγ in the absence of Jun.
Discussion
We demonstrate that AP-1 monomers have both distinct and
overlapping transcriptional functions and genome-wide binding
patterns in macrophages. Monomer-specific differences in DNA
binding are not due to differences in the DBD contact residues as
demonstrated by ATF3 chimeras with Jun or Fos DBDs. These
observations led us to hypothesize that monomer-specific DNA
binding patterns result from locus-specific interactions with dif-
ferent ensembles of collaborating TFs. To address this question,
we developed a machine learning model that identified combi-
nations of motifs that are correlated with the binding of a TF.
Through this approach, we inferred TF cooperation via the
presence of DNA motifs correlated with the binding of each AP-1
monomer. Leveraging the natural genetic variation found
between C57BL/6J and BALB/cJ, we confirmed that mutations in
motifs predicted by TBA affect AP-1 binding. Finally, we con-
firmed that PPARγ plays a preferential role in coordinating Jun
binding in TGEMs.
In designing our machine learning model, we optimized for
interpretability. We leveraged logistic regression, a relatively
simple method, to accurately predict TF binding, and we were
able to extract TF motifs underlying these predictions, allowing
for the generation of biological hypotheses that can be experi-
mentally validated. A secondary benefit of this approach is that
the software can be readily used without specialized computing
equipment or a high level of computational understanding. To
improve the ability of TBA to robustly identify motifs of interest,
we programmatically curated a library that “captures” the core of
each motif, thereby mitigating collinearity, which can cause
machine learning models to produce inaccurate results. By jointly
weighing this library of motifs, TBA enables the detection of
combinations of TF binding sites that can predict the distinct and
overlapping DNA binding of families of TFs that recognize
similar sequences. More broadly, TBA can be applied to predict
the effects of mutations on TF binding, and identify determinants
of enhancer activation and open chromatin.
There are additional complexities in TF binding and enhancer
activation we have not explored. Transcriptional regulation may
be encoded by the spacing between motifs as well as the specific
arrangement of motifs. Recent neural network architectures, such
as CapsuleNets, could allow modeling of these complex proper-
ties45–47. Although more complex machine learning techniques
can be applied to predict TF binding and chromatin state48–50, it
is challenging to extract insights from these models. Efforts to
build more advanced methods to extract information from
machine learning models will allow not only for interpretation of
future models of greater complexity, but also better under-
standing of existing models51. For example, the procedure used
by Ghandi et al. to retrieve motifs from gkm-SVM can likely be
improved to retrieve additional PWMs40.
Collectively, our findings suggest two classes of collaborative
TFs: (1) highly ranked TFs that are strongly correlated with the
binding of all AP-1 monomers, including TFs important to
macrophage identity such as such as PU.1 and C/EBPs10,11,13,52–54
(Fig. 4a, black and gray boxes), and (2) moderately ranked TFs
that specify the binding of individual AP-1 monomers (Fig. 4a, red
and blue boxes). The former likely consists of TFs that play a role
in opening chromatin while the latter class of TFs may allow for
tuning the optimal level of transcriptional activation or response.
These two classes of motifs were also seen in TLR4 activated
macrophages where highly ranked motifs, such as NFκB, were
correlated with the binding of all AP-1 family members (Sup-
plementary Table 1), while a large set of moderately ranked motifs
distinguished each AP-1 monomer (Supplementary Fig. 5C).
Overall, these studies provide evidence that collaborative interac-
tions of TFs allow a single DNA motif to be used in a wide variety
of contexts, which may be a general principle for how transcrip-
tional specificity is encoded by the genome.
Methods
Statistical analyses. In Fig. 1c, differences in gene expression was tested using the
independent T-test (degree of freedom= 1, two-tailed) on two replicate experi-
ments (n= 2). Differentially expressed genes in Fig. 1b were identified using
EdgeR55 with default parameters, and using the cut offs FDR < 0.05 and log2 fold
change ≥2. In Fig. 2c, differences between each group (Veh, Shared, and KLA 1 h)
were examined using independent T-test (degree of freedom= 1, two-tailed); the
number of loci in each group for each monomer are as follows ATF3 (Veh= 1447,
Shared= 7460, KLA= 6997), Jun (2390, 3751, 3401), JunD (1351, 5976, 6422).
Significance for motifs in Fig. 4a was calculated using the likelihood ratio test
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Fig. 7 The Jun-specific DNA binding program is preferentially altered in PPARγ knockout macrophages. a–c Changes in binding strength all binding sites in
wild type macrophages in PPARγ-KO macrophages (left) and Venn diagrams summarizing the change in binding at binding sites that overlap with PPARγ
(right) for Jun (a), ATF3 (b), and JunD (c). d Representative browser shots of Jun in WT and PPARγ-KO thioglycollate elicited macrophages (TGEMs) and
PPARγ in WT TGEMs. e Western blot analysis of co-immunoprecipitation experiments between AP-1 monomers ATF3, Jun and JunD and PPARγ in
TGEMs. f Western blot analysis of co-immunoprecipitation experiments between AP-1 monomers ATF3 and JunD and PPARγ in scramble immortalized
bone marrow-derived macrophage (iBMDM) or CRISPR-mediated Jun knockout iBMDM
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(degree of freedom= 1) comparing the predictions made by the full TBA model
and the perturbed TBA model at all loci bound in Veh-treated macrophages for
Atf3 (n= 23,160), Jun (n= 15,548), and JunD (n= 19,653). Significance for motifs
in Supplementary Fig. 4C was calculated using the likelihood ratio test (degree of
freedom= 1) comparing the predictions made by the full TBA model and the
perturbed TBA model at all loci bound by JunD in GM12878 (n= 7451), H1-hESC
(n= 12,931), HepG2 (n= 41,318), K562 (n= 47,477), and SK-N-SH (38,960).
Significance for motifs in Fig. 5b, Supplementary Fig. 5B, and Supplementary
Fig. 5C was calculated using the likelihood ratio test (degree of freedom= 1)
comparing the predictions made by the full TBA model and the perturbed TBA
model at all loci bound in KLA treated macrophages for Atf3 (n= 36,745), Jun
(n= 17,481), JunD (n= 31,641), Fos (n= 24,365), Fosl2 (n= 10,619), and JunB
(n= 13,376). Significance values for Fig. 6f and S6F were calculated using the
F-test; the number of loci analyzed for monomers in Vehicle-treated macrophages
are ATF3 (n= 4163), Jun (n= 3004), and JunD (n= 4148); the number of loci
analyzed for monomers in KLA-treated macrophages are: Atf3 (n= 4577), Jun
(n= 3232), JunD (n= 4366), Fos (n= 4477), and JunB (n= 3616).
Generating custom genome for BALB/cJ. A custom genome for BALB/cJ by
replacing invariant positions of the mm10 genome with alleles reported by the
Mouse Genomes Project (version 3 VCF file)43. For C57BL/6J the mm10 reference
genome from the UCSC genome browser was used. To allow for comparisons
between BALB/cJ and C57BL/6J during analysis, the coordinates for the custom
genome for BALB/cJ was shifted to match the positions of the mm10 reference
genome using MARGE34. We did not analyze any reads that fell within deletions in
BALB/cJ. Reads that overlapped with an insertion were assigned to the last over-
lapping position in the reference strain.
Analysis of ChIP-seq peaks. Sequencing reads from ChIP-seq experiments were
mapped to the mm10 assembly of the mouse reference genome (or the BALBc/J
custom genome) using the latest version of Bowtie2 with default parameters56.
Mapped ChIP-seq reads to identify putative TF binding sites with HOMER57
findPeaks command (with parameters -size 200 -L 0 -C 0 -fdr 0.9), using the input
ChIP experiment corresponding to the treatment condition. In order to reduce the
number of false positive peaks, we calculated the IDR at each peak (using version
2.0.3 of the idr program) with the HOMER peak score calculated for each replicate
experiment as the input to IDR and then filtered all peaks that had IDR ≥ 0.0558.
De novo motifs were calculated with the HOMER findMotifsGenome.pl command
with default parameters. Enrichment of de novo motifs was calculated using the
findKnownMotifs.pl program in HOMER with default parameters.
Quantification of RNA expression reads generated from RNA-seq experiments
were aligned to the mm10 mouse reference genome (or the BALBc/J custom
genome) using STAR aligner with default parameters59. To quantify the expression
level of each gene, we calculated the RPKM with the reads that were within an exon.
Un-normalized sequencing reads were used to identify differentially expressed genes
with EdgeR55; we considered genes with FDR < 0.05 and a change in expression
between two experimental conditions two fold or greater differentially expressed. To
quantify the expression of nascent RNAs we annotated our ChIP-seq peaks with the
number of GRO-seq reads (normalized to 10 million) that were within 500 bps of
the peak center using the HOMER annotatePeaks.pl command.
TBA model training. For each AP-1 monomer under each treatment condition, we
trained a model to distinguish binding sites for each monomer from a set of
randomly selected genomic loci. The set of random background loci used to train
each model was selected according to the following criteria: (1) the GC content
distribution of the background loci matches the GC content of the binding sites for
a given monomer, (2) contain no ambiguous or unmappable positions, and (3) the
number of background sequences matches the number of binding sites k. For each
of the sequences in the combined set of the binding sites and background loci, we
calculated the highest log-odds score (also referred to as motif score) for each of the
n motifs that will be included in the model60 Motif matches in both orientations
were considered. Log-odds scores less than 0 were set to 0. Per standard pre-
processing procedures prior to training a linear model, we standardized the log-
odds scores for each motif, scaling the set of scores for each motif so that the mean
value is 0, and the variance is 1. Standardization scales the scores for all motifs to
the same range (longer motifs have a larger maximum score) and also helps to
reduce the effect of multi-collinearity on the model training. And so, the features
used for training our model is an n by 2k matrix of log-odds scores standardized
across each row. To generate the corresponding array of labels, we assigned each
binding site a label of 1 and each background loci a label of 0. Using this feature
matrix, and label array, we trained weights for each motif using an L1 penalized
logistic regression model as implemented by the scikit-learn Python package61.
Motif weights shown in our analysis are the mean values across five rounds of
cross-validation, using 80% of the data for training and 20% for testing in each
round. Models were trained for ChIP-seqs generated in this study as well as data
downloaded from the NCBI Gene Expression Omnibus (accession number
GSE46494) and the ENCODE data portal (https://www.encodeproject.org).
Quantification of multiple collinearity. To assess the extent of multi-collinearity in
the motif score features we used to train our models, we took each feature matrix
corresponding to each experiment and calculated the VIF for each motif38. To cal-
culate the VIF, we first determine the coefficient of determination, R2, for each motif
by regressing the log-odds scores for one motif against the log-odds scores of the
remaining motifs. Next using the coefficient of determination, the tolerance for each
motif can be calculated as the difference between 1 and the coefficient of determination
(1− R2). The VIF is the reciprocal of the tolerance 11R2 . We used the linear_model
module of sklearn Python package to calculate the coefficient of determination.
Motif clustering and merging. We scored the similarity of all pairs of DNA
sequence motifs by calculating the Pearson correlation of the aligned position
probability matrices (PPMs) corresponding to a given pair of motifs62. The Pearson
correlation for a pair of motifs A and B of length i is calculated using the formula:
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PPMs were first aligned using the Smith–Waterman alignment algorithm63.
Shorter motifs are padded with background frequency values prior to alignment.
Gaps in the alignment were not allowed and each position in the alignment was
scored with the Pearson correlation. The Pearson correlation was then calculated
using the optimal alignment. Next, sets of motifs that have PPMs with a Pearson
correlation of 0.9 or greater were merged by iteratively aligning each PPM within
the set, and then averaging the nucleotide frequencies at each position.
Assessing significance of motifs for TBA. p-Values for TBA were calculated using
the log-likelihood ratio test. Each motif was removed from the set of features used to
train a perturbed TBA model (using five-fold cross-validation). We then used the full
model (containing all motifs) and the perturbed model to calculate the likelihood of
observing binding on all binding sites and background sequences for a given monomer
and all the background regions. The difference in the likelihoods calculated by the full
model and the perturbed model was then used to perform the chi-squared test for each
motif. The chi-squared test was performed using the scipy python package64.
Comparison to other methods. BaMM motif and gkm-SVM were both run with
default parameters. We used the latest version of the larger scale gkm-SVM, LS-
GKM (compiled from source code downloaded from https://github.com/
Dongwon-Lee/lsgkm on 8/25/16), and BaMMmotif; v1.0 downloaded from https://
github.com/soedinglab/BaMMmotif39,65. Both models were trained using five-fold
cross-validation. Model performance was scored using roc_auc_score and pre-
cision_score functions from the metrics module of sklearn.
Predicting changes in AP-1 binding after one-hour KLA treatment. To predict
the change in binding after KLA treatment, we leveraged the motif weights learned
for each of the n motifs (wn) by a TBA model trained on the Vehicle-treated data
(Wveh= [wveh,1,…wveh,n]) and a TBA model trained on the 1-h KLA treated data
(Wkla= [wkla,1,…wkla,n]) for each AP-1 monomer. The predicted change in binding
for each sequence is then the difference between the dot product of the standar-
dized motif scores calculated for the sequence each of the k binding sites (Sk= [s1,k,
…,sn,k]) with the KLA motif weights and the dot product of the motif scores and
the Veh motif weights (Δkla−veh,k = Wkla⋅Sk−Wveh⋅Sk). Predictions were made for
all genomic loci that intersected with a peak for one of the AP-1 monomers in
either the vehicle or KLA treatment condition.
Predicting strain-specific binding with TBA. To predict strain-specific binding,
we leveraged the motif weights learned for each of the nmotifs (wn) by a TBA model
(W= [w1,…,wn]) for each AP-1 monomer using the C57BL/6J data, and the motif
scores calculated for each of the k binding sites using the genomic sequence for
C57BL/6J and BALBc/J (SC57,k= [sC57,1,k,…,sC57,n,k], SBAL,k= [sBAL,1,k,…,sBAL,n,k]).
Next, we computed the difference of the motif scores for C57BL6/J and BALBc/J
(Dn= [sC57,n,1− sBAL,n,1,…,sC57,n,k− sBAL,n,k]) and then standardized the score dif-
ferences for each motif across all the k binding sites that had a mutation when
comparing BALBc/J to C57BL/6J, yielding standardized motif score differences for
each binding site (Zn= standardize(Dn)= [zn,1,…,zn,k]). Finally, we then made a
prediction for strain-specific binding by computing the dot product of the motif
weights and the standardized difference of the motif scores between C57BL6/EiJ and
BALBc/J for the kth mutated binding site (ΔC57−BAL=W⋅[z1,k,…,zn,k]).
TBA-2Strain model training. For each genomic loci that intersected with a peak for
one of the AP-1 monomers, in either C57BL/6J or BALBc/J, we calculated the highest
log-odds score for each of the n motifs that will be included in the model, using the
genomic sequence from both strains, yielding a two sets of motif scores for each of
the k binding sites (SC57,k= [sC57,1,k,…,sC57,n,k], SBAL,k= [sBAL,1,k,…,sBAL,n,k]). Motif
matches in both orientations were considered. Log-odds scores less than 0 were set to
0. Using the motif scores, we compute the standardized difference of the motif scores
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across the two strains as described in the above section (Zn= [zn,1,…,zn,k]). And so,
the features used for training our model is an n by k matrix of log-odds scores
standardized across each row. Next, we calculated the log2 fold ratio of the number
of ChIP-seq reads in C57BL/6J compared to BALBc/J to represent the extent of
strain-specific binding. Using this feature matrix, and setting the log2 fold ratio of
binding between the two strains as the dependent variable, we trained weights for
each motif using linear regression as implemented by the scikit-learn Python
package. Motif weights shown in our analysis are the mean values across five rounds
of cross-validation, using 80% of the data for training and 20% for testing in each
round. Predictions for strain-specific binding can be made using the calculated
weights following the procedure in the previous section.
ChIP protocol. Protein A and G Dynabeads 50/50 mix from Invitrogen are sued
for ChIP (10001D, 10003D). IP mix consists of 20 μL beads/2 μg antibody per 2
million cell ChIP. Antibodies against AP-1 family members were chosen for tar-
geting of non-conserved regions to minimize the potential for non-specific binding.
Antibodies are listed in Supplementary Table 3. For preparation, beads were
washed with 2× 0.5% BSA–PBS, then beads–antibody were incubated with 0.5%
BSA–PBS for at least 1 h on rotator (4 °C). Wash 2× with 0.5% BSA–PBS, then
resuspended in dilution buffer (1% Triton, 2 mM EDTA, 150 mM NaCl, 20 mM
Tris–HCl (pH 7.4), 1× Protease Inhibitors). Double crosslinking for ChIP: Media
was decanted from cells in 10 cm plates, wash once briefly with PBS (RT). Dis-
uccinimidyl glutarate (Pierce Cat # 20593) (diluted in DMSO at 200 mM)/PBS
(RT) was used for 10 min. Then formaldehyde was added to a final concentration
of 1% for an additional 10 min. Reaction was quenched with 1:10 1M Tris pH 7.4
on ice. Cells were collected and washed twice with cold PBS, spinning at 1000 × g
for 5 min. Nuclei isolation and sonication: Resuspend cell pellets in 1 mL of nuclei
isolation buffer (50 mM Tris–pH 8.0, 60 mM KCl, 0.5% NP40)+ PI and incubate
on ice for 10 min. Centrifuge 2000 × g for 3 min at 4 °C. Resuspend nuclei in 200 μL
of fresh lysis buffer (0.5% SDS, 10 mM EDTA, 0.5 mM EGTA, 50 mM Tris–HCl
(pH 8))+ PI. Sonication: Nuclei were then sonicated (10 million cells) for 25 min
in a Biorupter (settings= 30 s=On, 30 s=Off, Medium) using thin wall tubes
(Diagenode Cat# C30010010). After sonication spin max speed for 10 min at 4 °C.
ChIP set up: Sonicated DNA was diluted 5× with 800 Dilution Buffer (1% Triton, 2
mM EDTA, 150 mM NaCl, 20 mM Tris–HCl (pH 7.4), 1× protease inhibitors). An
aliquot is removed for input samples (5%). Samples ON at 4 °C while rotating.
Washing: ChIP are washed 1× with TSE I (20 mM Tris–HCl pH 7.4, 150 mM NaCl,
0.1% SDS, 1% Triton X-100, 2 mM EDTA), 2× with TSE III (10 mM Tris–HCl pH
7.4, 250 mM LiCl, 1% IGEPAL, 1% deoxycholate, 1 mM EDTA), 1× with TE+
0.1% Triton X-100, transfer to new tube and then wash another time with TE+
0.1% Triton X-100. Elution: Elute with 200 μL elution buffer (1% SDS, 10 mM Tris
pH 7.5) for 20 min at RT, shaking on the vortex or a nutator or rotator. De-
crosslinking: Add 10 μL of 5M NaCl and incubate ON at 65 °C (or at least 8 h).
Clean up samples using Zymo ChIP DNA Clean and Concentrator. Elute in
100 μL. Take 40 μL and proceed to library prep protocol.
PolyA RNA isolation and fragmentation. RNA isolation: RNA was isolated using
TRIZOL-reagent (Ambion cat# 15596018) and DIRECT-ZOL RNA mini-prep kit
(cat# 11-330MB). Poly-A RNA isolation: Use 0.2 total RNA as starting material for
ideal mapping efficiency and minimal clonality. Collect 10 μL oligo (dT) (NEB cat#
S1419S) beads per RNA sample. Beads were washed twice with 1× DTBB (20 mM
Tris–HCl pH 7.5, 1 M LiCl, 2 mM EDTA, 1% LDS, 0.1% Triton X-100). Beads were
resuspended in 50 μL of 2× DTBB. 50 μL of beads were mixed with 50 μL RNA and
heated to 65 °C for 2 min. RNA-beads were then incubated for 10 min at RT while
rotating. RNA-beads were then collected on a magnet and washed 1× each with
RNA WB1 (10 mM Tris–HCl pH 7.5, 0.12 M LiCl, 1 mM EDTA, 0.1% LDS, 0.1%
Triton X-100) and WB3 (10 mM Tris–HCl pH 7.5, 0.5 M LiCl, 1 mM EDTA). Add
50 μL Tris–HCl pH 7.5 and heat to 80 °C for 2 min to elute. Collect RNA and
perform a second Oligo-dT bead collection. After washing the second collection,
instead of eluting was 1× with 1× first strand buffer; 250 mM Tris–HCl (pH 8.3),
375 mM KCl, 15 mM MgCL2 (ThermoFisher SSIII kit Cat# 18080093). Fragmen-
tation: Then add 10 μL of 2× first strand buffer plus 10 mM DTT and fragment
DNA at 94 °C for 9 min. Collect beads on magnet and transfer eluate containing
fragmented mRNA to a new PCR strip. Should recover 10 μL fragmented RNA.
First strand synthesis: We mixed fragmented RNA with 0.5 μL random primer (3
μg/μL) Life Tech #48190-011, 0.5 μL oligo-dT (50 μM from SSIII kit), 1 μL dNTPs
(10 mM Life Tech, cat 18427088) and 0.5 μL SUPERase-In (ThermoFisher
Cat#AM2696) and heat 50 °C for 1 min. Immediately place on ice. We then added
5.8 μL ddH2O, 0.1 μL actinomycin (2 μg/μL Sigma cat#A1410), 1 μL DTT (100 mM
Life Tech cat# P2325), 0.2 μL of 1% Tween and 0.5 μL of Superscript III and
incubate 25 °C for 10 min, then 50 °C for 50 min. Bead clean up: We added 36 μL of
RNAClean XP (Ampure XP) and mixed, incubating for 15 min on ice. The beads
were then collected on a magnet and washed 2× with 75% ethanol. Beads were then
air-dried for 10 min and elute with 10 μL nuclease-free H2O. Second strand
synthesis. 10 μL of cDNA/RNA was mixed with 1.5 μL 10× Blue Buffer (Enzymatics
cat# B0110L), 1 μL dUTP/dNTP mix (10 mM Affymetrix cat# 77330), 0.1 μL dUTP
(100 mM Affymetrix cat# 77206), 0.2 μL RNase H (5 U/μL Enzymatics cat#
Y9220L), 1 μL DNA polymerase I (10 U/μL Enzymatics cat#P7050L), 0.15 μL 1%
Tween-20 and 1.05 μL nuclease-free water. Reaction was incubated at 16 °C for 2.5
h. Bead clean up: DNA was purified by adding 1 μL Seradyn 3 EDAC SpeedBeads
(Thermo 6515-2105-050250) per reaction in 28 μL 20% PEG8000/2.5 M NaCl (13%
final concentration) and incubating at RT for 10 min. Beads were then collected on
a magnet and washed 2× with 80% ethanol. Beads were air-dried for 10 min and
eluted in 40 μL of nuclease-free water. DNA is ready for library prep.
Library prep protocol. dsDNA end repair: We mixed 40 μL of DNA from ChIP or
RNA protocols with 2.9 μL of H2O, 0.5 μL 1% Tween-20, 5 μL 10× T4 ligase buffer
(Enzymatics cat# L6030-HC-L), 1 μL dNTP mix (10 mM Affymetrix 77119), 0.3 μL
T4 DNA pol (Enzymatics P7080L), 0.3 μL T4 PNK (Enzymatics Y9040L), 0.06 μL
Klenow (Enzymatics P7060L) and incubated for 30 min at 20 °C. 1 μL of Seradyn 3
EDAC SpeedBeads (Thermo 6515-2105-050250) in 93 μL 20% PEG8000/2.5 M
NaCl (13% final) was added and incubated for 10 min. Bead clean-up: Beads were
collected on a magnet and washed 2× with 80% ethanol. Beads were air-dried for
10 min and then eluted in 15 μL ddH2O. dA-Tailing. DNA was mixed with 10.8 μL
ddH2O, 0.3 μL 1% Tween-20, 3 μL Blue Buffer (Enzymatics cat# B0110L), 0.6 μL
dATP (10 mM Tech 10216-018), 0.3 μL Klenow 3-5 Exo (Enzymatics P7010-LC-L)
and incubated for 30 min at 37 °C. 55.8 μL 20% PEG8000/2.5 M NaCl (13% final)
was added an incubated for 10 min. Then bead clean up was done. Beads were
eluted in 14 μL. Y-shape adapter ligation. Sample was mixed with 0.5 μL of a BIOO
barcode adapter (BIOO Scientific cat# 514104), 15 μL Rapid Ligation Buffer
(Enzymatics cat@ L603-LC-L), 0.33 μL 1% Tween-20 and 0.5 μL T4 DNA ligase
HC (Enzymatics L6030-HC-L) and incubated for 15 min at RT. 7 μL of 20%
PEG8000/2.5 M NaCl was added and incubated for 10 min at RT. Bead clean up
was performed and beads were eluted in 21 μL. 10 μL was then used for PCR
amplification (14 cycles) with IGA and IGB primers (AATGATACGGCGA
CCACCGA, CAAGCAGAAGACGGCATACGA).
GRO-seq. Nascent transcription was captured by global nuclear run-on sequencing
(GRO-seq). Nuclei were isolated from TGEMs using hypotonic lysis (10 mM
Tris–HCl (pH 7.5), 2 mM MgCl2, 3 mM CaCl2; 0.1% IGEPAL CA-630) and flash
frozen in GRO-freezing buffer (50 mM Tris–HCl (pH 7.8), 5 mM MgCL2, 40%
Glycerol). Run-on. 3–5 × 106 BMDM nuclei were run-on with BrUTP-labeled
NTPs with 3× NRO buffer (15 mM Tris–Cl (pH 8.0), 7.5 mMMgCl2, 1.5 mM DTT,
450 mM KCl, 0.3 U/μL of SUPERase In, 1.5% Sarkosyl, 366 μM ATP, GTP (Roche),
Br-UTP (Sigma 40 Aldrich) and 1.2 μM CTP (Roche, to limit run-on length to ~40
nucleotides)). Reactions were stopped after 5 min by addition of 500 μL Trizol LS
reagent (Invitrogen), vortexed for 5 min and RNA extracted and precipitated as
described by the manufacturer. RNA pellets were resuspended in 18 μL ddH2O+
0.05% Tween (dH2O+ T) and 2 μL fragmentation mix (100 mMZnCL2, 10 mM
Tris–HCl (pH 7.5)), then incubated at 70 °C for 15 min. Fragmentation was
stopped by addition of 2.5 μL of 100 mM EDTA. BrdU enrichment. BrdU
enrichment was performed using BrdU antibody (IIB5) and AC beads (Santa Cruz,
sc-32323 AC, lot #A0215 and #C1716). Beads were washed once with GRO binding
buffer (0.25× saline-sodium-phosphate-EDTA buffer (SSPE), 0.05% (vol/vol)
Tween, 37.5 mM NaCl, 1 mM EDTA)+ 300 mM NaCl followed by three washes in
GRO binding buffer and resuspended as 25% (vol/vol) slurry with 0.1 U/μL
SUPERase-in. To fragment RNA, 50 μL cold GRO binding buffer and 40 μL
equilibrated BrdU antibody beads were added and samples slowly rotated at 4 °C
for 80 min. Beads were subsequently spun down at 1000 × g for 15 s, supernatant
removed and the beads transferred to a Millipore Ultrafree MC column
(UFC30HVNB; Millipore) in 2 × 200 μL GRO binding buffer. The IP reaction was
washed twice with 400 μL GRO binding buffer before RNA was eluted by incu-
bation in 200 μL Trizol LS (ThermoFisher) under gentle agitation for 3 min. The
elution was repeated a second time, 120 μL of dH2O+ T added to increase the
supernatant and extracted as described by the manufacturer. End repair and
decapping: For end-repair and decapping, RNA pellets were dissolved in 8 μL TET
(10 mM Tris–HCl (pH 7.5), 1 mM EDTA, 0.05% Tween 20) by vigorous vortexing,
heated to 70 °C for 2 min and placed on ice. After a quick spin, 22 μL Repair master
mix (3 μL 10× PNK buffer, 15.5 μL dH2O+ T, 0.5 μL SUPERase-In RNase Inhi-
bitor (10 U), 2 μL PNK (20U), 1 μL RppH (5U)) was added, mixed and incubated at
37 °C for 1 h. To phosphorylate the 5′end, 0.5 μL 100 mM ATP was subsequently
added and the reactions were incubated for another 45 min at 37 °C (the high ATP
concentration quenches RppH activity). Following end repair, 2.5 μL 50mM EDTA
was added, reactions mixed and then heated to 70 °C for 2 min before being placed
on ice. A second BrdU enrichment was performed as detailed above. RNA pellets
were dissolved in 2.75 μL TET+ 0.25 μL Illumina TruSeq 3′Adapter (10 μM),
heated to 70 °C for 2 min and placed on ice. 7 of 3′master mix (4.75 μL 50%
PEG8000, 1 μL 10× T4 RNA ligase buffer, 0.25 μL SUPERase-In, 1 μL T4 RNA
Ligase 2 truncated (200U; NEB)) was added, mixed well and reactions incubated at
20 °C for 1 h. Reactions were diluted by addition of 10 μL TET+ 2 μL 50mM
EDTA, heated to 70 °C for 2 min, placed on ice and a third round of BrUTP
enrichment was performed. RNA pellets were transferred to PCR strips during the
75% ethanol wash and dried. Samples were dissolved in 4 μL TET (10 mM
Tris–HCl (pH 7.5), 0.1 mM EDTA, 0.05% Tween 20)+ 1 μL 10 μM reverse tran-
scription (RT) primer. To anneal the RTprimer, the mixture was incubated at 75 °C
for 5 min, 37 °C for 15 min and 25 °C for 10 min. To ligate the 5′ Illumina TruSeq
adapter, 10 μL 5′master mix (1.5 μL dH2O+ 0.2% Tween 20, 0.25 μL denaturated
5′TruSeq adapter (10 μM), 1.5 μL 10× T4 RNA ligase buffer, 0.25 μL SUPERase-In,
0.2 μL 10mM ATP, 5.8 μL 50% PEG8000, 0.5 μL T4 RNA ligase 1 (5U; NEB)) was
added and reactions were incubated at 25 °C for 1 h. Reverse transcription was
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performed using Protoscript II (NEB) (4 μL 5× NEB FirstStrand buffer (NEB;
E7421AA), 0.25 μL SUPERase-In, 0.75 μL Protoscript II (150U; NEB)) at 50 °C for
1 h. After addition of 30 μL PCR master mix (25 μL 2× LongAmp Taq 2× Master
Mix (NEB), 0.2 μL 100 μM forward primer, 2.8 μL 5M betaine and 2 μL 10 μM
individual barcoding primer), mixtures were amplified (95 °C for 3 min, (95 °C for
60 s, 62 °C for 30 s, 72 °C for 15 s) x13, 72 °C for 3 min). PCR reactions were
cleaned up using 1.5 volumes of SpeedBeads (GE Healthcare) in 2.5 M NaCl/20%
PEG8000. Libraries were size selected on PAGE/TBE gels to 160–225 base pairs.
Gel slices were shredded by spinning through a 0.5 mL perforated PCR tube placed
on top of a 1.5 mL tube. 150 μL Gel EB (0.1% LDS, 1 M LiCl, 10 mM Tris–HCl (pH
7.8)) was added and the slurry incubate under agitation overnight. To purify the
eluted DNA, 700 μL Zymogen ChIP DNA binding buffer was added into the 1.5mL
tube containing the shredded gel slice and the Gel EB, mixed by pipetting and the
slurry transferred to a ZymoMiniElute column. Samples were first spun at 1000 × g
for 3 min, then 10,000×g for 30 s. Flow through was removed, and samples washed
with 200 μl ZymoWashBuffer (with EtOH). Gel remainders were removed by flicking
and columns washed by addition of another 200 μL Zymo WashBuffer (with EtOH).
Flow through was removed, columns spun dry by centrifugation at 14,000 × g for 1
min and DNA eluted by addition of 20 μL pre-warmed Sequencing TET (10mM
Tris–HCl (pH 8.0), 0.1mM EDTA, 0.05% Tween 20). Libraries were sequenced.
Western blotting. Cells were lysed with Igepal lysis buffer (50 mM Tris pH 8.0,
150 mM NaCl, 0.5% Igepal) and protein concentrations were determined with
BioRad protein assay reagent using BSA as a standard. Proteins were separated on
NuPage 4–12% Bis–Tris gradient gels (Invitrogen) and transferred onto a nitro-
cellulose membrane (Amersham). Membranes were blocked in TBS with 0.1%
Tween-20 and 5% BSA. Membranes were blotted with the indicated primary
overnight at 4 °C. Horseradish peroxidase-conjugated secondary antibodies were
detected using ECL plus western blotting detection system (Amersham).
Animals and cell culture. TGEMs were collected 3 days after injection from male
8-week C57Bl/6J, or BALB/cJ mice, and plated at 20 × 106 cells per 15 cm Petri dish
in DMEM plus 10% FBS and 1× penicillin–streptomycin. One day after plating, cells
were supplemented with fresh media and treated with PBS (Veh) or 100 ng/mL
KLA for 1 h, and then directly used for downstream analyses. iBMDM are produced
by infection of BMDM with a retrovirus containing myc and Braf V600E66. The
immortalized cells are then grown out over several weeks. All animal experiments
were performed in compliance with the ethical standards set forth by University of
California, San Diego Institutional Annual Care and Use Committee (IUCAC).
Lentivirus production. pLentiguide was modified to contain a U6-bsmbi-spgRNA
scaffold and a CMV promoter driving tagBFP2. 2 CRISPR guides were inserted for
each target via PCR amplification with the H1 promoter (bsmbi site/guide1/scaf-
fold/H1 promoter/guide 2/bsmb1 site) for a total of 2 guides per virus (U6 and H1
driven) (Supplementary Table 4). Virus was made with pVSVg/ppAX2 system.
Two days post transfection, media was collected and centrifuged at 4 °C for 2 h at
20,000 × g. Cell pellet was reconstituted overnight at 4 °C in OPTI-MEM and
stored at −80 °C.
Production of CRISPR KO iBMDMs. KO iBMDMs were produced using lentiviral
infection. iBMDM-CAS9-IRES-EGFP were infected with MOI 100, as measured on
293T cells, with Lentiblast (OZ biosciences) (5 μL each reagent) in OPTI-MEM.
This was then centrifuged at 1300g for 1 h at room temperature. Media was then
removed and cells were supplemented in bone marrow media (30% L-cell, 20%
FBS, 1% penicillin/streptomycin in DMEM) for 2 days. Cells were then sorted for
infection by expression of a transgene on the viral sequence (tagBFP2).
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Code availability. All algorithms relating to training and testing our model, TBA,
has been implemented using Python. Source code and executable files are available
at: https://github.com/jenhantao/tba.
Data availability
Data generated for this study has been deposited to the NCBI Gene Expression
Omnibus (GEO) under the accession number GSE111856. Previously published
data was downloaded from GEO (accession number GSE46494) and the ENCODE
data portal (https://www.encodeproject.org). A reporting summary for this Article
is available as a Supplementary Information file. The individual data points
underlying all figures and tables that report average values as well as uncropped
versions of gels and blots are available as Source Data file.
Received: 13 June 2018 Accepted: 13 December 2018
References
1. Heinz, S., Romanoski, C. E., Benner, C. & Glass, C. K. The selection and function
of cell type-specific enhancers. Nat. Rev. Mol. Cell Biol. 16, 144–154 (2015).
2. Levine, M. Transcriptional enhancers in animal development and evolution.
Curr. Biol. 20, R754–R763 (2010).
3. Shlyueva, D., Stampfel, G. & Stark, A. Transcriptional enhancers: from
properties to genome-wide predictions. Nat. Rev. Genet. 15, 272–286 (2014).
4. Andersson, R. et al. An atlas of active enhancers across human cell types and
tissues. Nature 507, 455–461 (2014).
5. Lara-Astiaso, D. et al. Chromatin state dynamics during blood formation.
Science 345, 943–949 (2014).
6. Anshul Roadmap Epigenomics Consortium et al. Integrative analysis of 111
reference human epigenomes. Nature 518, 317–330 (2015).
7. Villar, D. et al. Enhancer evolution across 20 mammalian species. Cell 160,
554–566 (2015).
8. Barozzi, I. et al. Coregulation of transcription factor binding and nucleosome
occupancy through DNA features of mammalian enhancers. Mol. Cell 54,
844–857 (2014).
9. Gosselin, D. et al. Environment drives selection and function of enhancers
controlling tissue-specific macrophage identities. Cell 159, 1327–1340 (2014).
10. Heinz, S. et al. Effect of natural genetic variation on enhancer selection and
function. Nature 503, 487–492 (2013).
11. Kaikkonen, M. U. et al. Remodeling of the enhancer landscape during
macrophage activation is coupled to enhancer transcription. Mol. Cell 51,
310–325 (2013).
12. Lavin, Y. et al. Tissue-resident macrophage enhancer landscapes are shaped by
the local microenvironment. Cell 159, 1312–1326 (2014).
13. van Oevelen, C. et al. C/EBPα activates pre-existing and de novo macrophage
enhancers during induced pre-B cell transdifferentiation and myelopoiesis.
Stem Cell Rep. 5, 232–247 (2015).
14. Whyte, W. A. et al. Master transcription factors and mediator establish super-
enhancers at key cell identity genes. Cell 153, 307–319 (2013).
15. Wingender, E., Schoeps, T., Haubrock, M., Krull, M. & Dönitz, J. TFClass:
expanding the classification of human transcription factors to their
mammalian orthologs. Nucleic Acids Res. 46, D343–D347 (2018).
16. Isakova, A. et al. SMiLE-seq identifies binding motifs of single and dimeric
transcription factors. Nat. Methods 14, 316–322 (2017).
17. Sandelin, A., Alkema, W., Engström, P., Wasserman, W. W. & Lenhard, B.
JASPAR: an open-access database for eukaryotic transcription factor binding
profiles. Nucleic Acids Res. 32, D91–D94 (2004).
18. Chen, H. & Jiang, Z. The essential adaptors of innate immune signaling.
Protein Cell 4, 27–39 (2013).
19. Hess, J., Angel, P. & Schorpp-Kistner, M. AP-1 subunits: quarrel and harmony
among siblings. J. Cell Sci. 117, 5965–5973 (2004).
20. Jochum, W., Passegué, E. & Wagner, E. F. AP-1 in mouse development and
tumorigenesis. Oncogene 20, 2401–2412 (2001).
21. Reddy, S. P. M. & Mossman, B. T. Role and regulation of activator protein-1 in
toxicant-induced responses of the lung. Am. J. Physiol. Lung Cell. Mol. Physiol.
283, L1161–L1178 (2002).
22. Tempé, D. et al. SUMOylation of the inducible (c-Fos:c-Jun)/AP-1
transcription complex occurs on target promoters to limit transcriptional
activation. Oncogene 33, 921–927 (2014).
23. Porte, D., Oertel-Buchheit, P., John, M., Granger-Schnarr, M. & Schnarr, M.
DNA binding and transactivation properties of Fos variants with
homodimerization capacity. Nucleic Acids Res. 25, 3026–3033 (1997).
24. Halazonetis, T. D., Georgopoulos, K., Greenberg, M. E. & Leder, P. c-Jun
dimerizes with itself and with c-Fos, forming complexes of different DNA
binding affinities. Cell 55, 917–924 (1988).
25. Lee, S.-Y. et al. The role of heterodimeric AP-1 protein comprised of JunD and
c-Fos proteins in hematopoiesis. J. Biol. Chem. 287, 31342–31348 (2012).
26. Nakabeppu, Y. & Nathans, D. The basic region of Fos mediates specific DNA
binding. EMBO J. 8, 3833–3841 (1989).
27. Hasenfuss, S. C. et al. Regulation of steatohepatitis and PPARγ signaling by
distinct AP-1 dimers. Cell Metab. 19, 84–95 (2014).
28. Johnson, R. S., Spiegelman, B. M. & Papaioannou, V. Pleiotropic effects of a
null mutation in the c-fos proto-oncogene. Cell 71, 577–586 (1992).
29. Okazaki, K. & Sagata, N. The Mos/MAP kinase pathway stabilizes c-Fos by
phosphorylation and augments its transforming activity in NIH 3T3 cells.
EMBO J. 14, 5048–5059 (1995).
30. Wang, Z. Q. et al. Bone and haematopoietic defects in mice lacking c-fos.
Nature 360, 741–745 (1992).
31. Chen, L., Glover, J. N. M., Hogan, P. G., Rao, A. & Harrison, S. C. Structure of
the DNA-binding domains from NFAT, Fos and Jun bound specifically to
DNA. Nature 392, 42–48 (1998).
32. Murphy, T. L., Tussiwand, R. & Murphy, K. M. Specificity through
cooperation: BATF-IRF interactions control immune-regulatory networks.
Nat. Rev. Immunol. 13, 499–509 (2013).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-08236-0 ARTICLE
NATURE COMMUNICATIONS |          (2019) 10:414 | https://doi.org/10.1038/s41467-018-08236-0 |www.nature.com/naturecommunications 15
33. Verger, A. et al. Identification of amino acid residues in the ETS transcription
factor Erg that mediate Erg-Jun/Fos-DNA ternary complex formation. J. Biol.
Chem. 276, 17181–17189 (2001).
34. Link, V. M. et al. Transcription factor landscapes in macrophages from
genetically diverse mice reveal extensive connected regulatory domains. Cell
173, 1796–1809 (2018).
35. Raetz, C. R. H. et al. Kdo2-Lipid A of Escherichia coli, a defined endotoxin that
activates macrophages via TLR-4. J. Lipid Res. 47, 1097–1111 (2006).
36. Core, L. J., Waterfall, J. J. & Lis, J. T. Nascent RNA sequencing reveals
widespread pausing and divergent initiation at human promoters. Science 322,
1845–1848 (2008).
37. Hai, T. & Curran, T. Cross-family dimerization of transcription factors Fos/
Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. U.S.
A. 88, 3720–3724 (1991).
38. Belsley, D. A., Kuh, E. & Welsch, R. E. Regression Diagnostics. Wiley Series in
Probability and Statistics. (John Wiley & Sons, Inc., Hoboken, NJ, USA, 1980).
39. Siebert, M., Soeding, J. & Johannes, S. Bayesian Markov models consistently
outperform PWMs at predicting motifs in nucleotide sequences. Nucleic Acids
Res. 44, 6055–6069 (2016).
40. Ghandi, M., Lee, D., Mohammad-Noori, M. & Beer, M. A. Enhanced
regulatory sequence prediction using gapped k-mer features. PLoS Comput.
Biol. 10, e1003711 (2014).
41. Iwafuchi-Doi, M. & Zaret, K. S. Pioneer transcription factors in cell
reprogramming. Genes Dev. 28, 2679–2692 (2014).
42. Wang, J. et al. Sequence features and chromatin structure around the genomic
regions bound by 119 human transcription factors. Genome Res. 9, 1798–1812
(2012).
43. Keane, T. M. et al. Mouse genomic variation and its effect on phenotypes and
gene regulation. Nature 477, 289–294 (2011).
44. Matsusue, K. et al. Liver-specific disruption of PPARgamma in leptin-deficient
mice improves fatty liver but aggravates d/types. J. Clin. Invest. 111, 737–747
(2003).
45. Bahdanau, D., Cho, K. & Bengio, Y. Neural machine translation by jointly
learning to align and translate. In: Proceedings of ICLR 2015, 1–15 (2014).
46. Sabour, S., Frosst, N. & Hinton, G. Dynamic routing between capsules. In:
NIPS Proceedings (2017).
47. Vaswani, A. et al. Attention is all you need. In: NIPS Proceedings (June 2017).
48. Alipanahi, B., Delong, A., Weirauch, M. T. & Frey, B. J. Predicting the
sequence specificities of DNA- and RNA-binding proteins by deep learning.
Nat. Biotechnol. 33, 831–838 (2015).
49. Kelley, D. R., Snoek, J. & Rinn, J. L. Basset: learning the regulatory code of the
accessible genome with deep convolutional neural networks. Genome Res. 26,
990–999 (2016).
50. Quang, D. & Xie, X. DanQ: a hybrid convolutional and recurrent deep neural
network for quantifying the function of DNA sequences. Nucleic Acids Res. 44,
e107 (2016).
51. Shrikumar, A., Greenside, P. & Kundaje, A. Learning important features
through propagating activation differences. arXiv (2017).
52. Heinz, S. & Glass, C. K. Roles of lineage-determining transcription factors in
establishing open chromatin: lessons from high-throughput studies. Curr.
Top. Microbiol. Immunol. 356, 1–15 (2012).
53. McKercher, S. R. et al. Targeted disruption of the PU.1 gene results in multiple
hematopoietic abnormalities. EMBO J. 15, 5647–5658 (1996).
54. Tavor, S. et al. Macrophage functional maturation and cytokine production
are impaired in C/EBP epsilon-deficient mice. Blood 99, 1794–1801 (2002).
55. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: A Bioconductor
package for differential expression analysis of digital gene expression data.
Bioinformatics 26, 139–140 (2009).
56. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat.
Methods 9, 357–359 (2012).
57. Heinz, S. et al. Simple combinations of lineage-determining transcription
factors prime cis-regulatory elements required for macrophage and B cell
identities. Mol. Cell 38, 576–589 (2010).
58. Li, Q., Brown, J. B., Huang, H. & Bickel, P. J. Measuring reproducibility of
high-throughput experiments. Ann. Appl. Stat. 5, 1752–1779 (2011).
59. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29,
15–21 (2013).
60. Stormo, G. D. Consensus patterns in DNA. Methods Enzymol. 183, 211–221
(1990).
61. Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn.
Res. 12, 2825–2830 (2012).
62. Mahony, S. & Benos, P. V. STAMP: a web tool for exploring DNA-binding
motif similarities. Nucleic Acids Res. 35, W253–W258 (2007).
63. Smith, T. F. & Waterman, M. S. Identification of common molecular
subsequences. Mol. Biol. 147, 195–197 (1981).
64. Jones, E. et al. SciPy: Open Source Scientific Tools for Python. 2001.
65. Lee, D. LS-GKM: a new gkm-SVM for large-scale datasets. Bioinformatics 32,
2196–2198 (2016).
66. Gandino, L. & Varesio, L. Immortalization of macrophages from mouse bone
marrow and fetal liver. Exp. Cell Res. 188, 192–198 (1990).
Acknowledgements
The authors thank L. Van Ael for assistance with manuscript preparation and J. Collier,
M. Pasillas, and Z. Ouyang for technical assistance. These studies were supported by NIH
Grants DK091183, CA17390, and GM085764 and Leducq Transatlantic Network Grant
16CVD01 to C.K.G. DNA sequencing was supported by NIH Grant DK063491. S.H.D. is
a CRI-Irvington Postdoctoral Fellow. T.S. was supported by the Swedish Society for
Medical Research. G.J.F. was supported by a Canadian Institute of Health Research
Postdoctoral Fellowship, FME-135475. M.S. was supported by the Manpei Suzuki Dia-
betes Foundation of Tokyo, Japan, and the Osamu Hayaishi Memorial Scholarship for
Study Abroad, Japan.
Author contributions
G.J.F., J.T., and C.K.G. conceived the study. G.J.F., J.T., E.M.W., S.H.D., J.D.S., T.S., N.J.S.,
M.S., and V.M.L. performed experiments. J.T., Z.S., G.J.F., C.B., and C.K.G. analyzed
data. G.J.F., J.T., and C.K.G. wrote the manuscript with contributions from C.B.
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
018-08236-0.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Journal peer review information: Nature Communications thanks the anonymous
reviewers for their contribution to the peer review of this work. Peer reviewer reports are
available.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2019
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-08236-0
16 NATURE COMMUNICATIONS |          (2019) 10:414 | https://doi.org/10.1038/s41467-018-08236-0 | www.nature.com/naturecommunications
